Randomized dose-finding study of batefenterol via dry powder inhaler in patients with COPD

BACKGROUND: Batefenterol is a novel bifunctional muscarinic antagonist β(2)-agonist in development for COPD. The primary objective of this randomized, double-blind, placebo-controlled, active comparator, Phase IIb study was to model the dose–response of batefenterol and select a dose for Phase III d...

Descripción completa

Detalles Bibliográficos
Autores principales: Crim, Courtney, Watkins, Michael L, Bateman, Eric D, Feldman, Gregory J, Schenkenberger, Isabelle, Kerwin, Edward M, Crawford, Catriona, Pudi, Krishna, Ho, Shuyen, Baidoo, Charlotte, Castro-Santamaria, Ramiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413745/
https://www.ncbi.nlm.nih.gov/pubmed/30880951
http://dx.doi.org/10.2147/COPD.S190603

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413745/
https://www.ncbi.nlm.nih.gov/pubmed/30880951
http://dx.doi.org/10.2147/COPD.S190603

Ejemplares similares